RecruitingNot ApplicableNCT07429487
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
Sponsor
Centre Antoine Lacassagne
Enrollment
98 participants
Start Date
Sep 15, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria7
- Patients aged 18 to 75 years old,
- Histologically proven non-metastatic adenocarcinoma of breast, colorectal, ovarian, pancreatic, biliary, or gastric origin,
- Adjuvant chemotherapy completed less than 3 months ago (excluding hormone therapy),
- PS 0 or 1 according to the World Health Organization (WHO) scale,
- No recurrence since the end of adjuvant chemotherapy,
- Patient who has voluntarily agreed to participate in the study and sign the written informed consent form,
- Patient affiliated with a Social Security scheme.
Exclusion Criteria12
- New cancer treatment planned (excluding hormone therapy),
- Patient who has received adjuvant immunotherapy,
- Cardiological contraindication to the program
- Decompensated or unstable chronic conditions
- Severe malnutrition
- Rheumatological unfitness as determined by the oncologist,
- Chronic respiratory failure requiring long-term O2 therapy
- Diabetes with plantar ulceration
- Progressive or chronic non-healing bedsore/wound
- Recent unhealed fracture
- Patient participating in another interventional clinical study at the time of signing the informed consent form.
- Vulnerable persons as defined in Articles L1121-5 to -8
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERAPA program
patient will benefit of an activity monitored by a wtach and an APA program during 3 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07429487
Related Trials
[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
NCT077022926 locations
Utility of a Mobile Application for Young Women With Breast Cancer
NCT070090931 location
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
NCT069702754 locations
Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
NCT076862501 location
PRIORITY-CONNECT 2 Trial
NCT0697671031 locations